Literature DB >> 16937525

Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro.

Yang Cheng1, Jian Ping, Huai-Dong Xu, Hai-Jun Fu, Zhao-Hui Zhou.   

Abstract

AIM: To study the effect of oxymatrine-baicalin combination (OB) against HBV replication in 2.2.15 cells and alpha smooth muscle actin (alpha SMA) expression, type I, collagen synthesis in HSC-T6 cells.
METHODS: The 2.2.15 cells and HSC-T6 cells were cultured and treated respectively. HBsAg and HBeAg in the culture supernatants were detected by ELISA and HBV DNA levels were determined by fluorescence quantitative PCR. Total RNA was extracted from HSC-T6 cells and reverse transcribed into cDNA. The cDNAs were amplified by PCR and the quantities were expressed in proportion to beta actin. The total cellular proteins extracted from HSC-T6 cells were separated by electrophoresis. Resolved proteins were electrophoretically transferred to nitrocellulose membrane. Protein bands were revealed and the quantities were corrected by beta actin.
RESULTS: In the 2.2.15 cell culture system, the inhibitory rate against secretion of HBsAg and HBeAg in the OB group was significantly stronger than that in the oxymatrine group (HBsAg, P = 0.043; HBeAg, P = 0.026; respectively); HBV DNA level in the OB group was significantly lower than that in the oxymatrine group (P = 0.041). In HSC-T6 cells the mRNA and protein expression levels of alpha SMA in the OB group were significantly lower as compared with those in the oxymatrine group (mRNA, P = 0.013; protein, P = 0.042; respectively); The mRNA and protein expression levels of type I collagen in the OB group were significantly lower as compared with those in the oxymatrine group (mRNA, P < 0.01; protein, P < 0.01; respectively).
CONCLUSION: OB combination has a better effect against HBV replication in 2.2.15 cells and is more effective against alpha SMA expression and type I collagen synthesis in HSC-T6 cells than oxymatrine in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937525      PMCID: PMC4088012          DOI: 10.3748/wjg.v12.i32.5153

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha.

Authors:  Chun-Song Wu; Xi-Xu Piao; Dong-Ming Piao; Yong-Ri Jin; Cheng-Hao Li
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.

Authors:  Yang Cheng; Sébastien Dharancy; Mathilde Malapel; Pierre Desreumaux
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 4.  Current treatment and future directions in the management of chronic hepatitis B viral infection.

Authors:  Robert G Gish
Journal:  Clin Liver Dis       Date:  2005-11       Impact factor: 6.126

5.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection.

Authors:  Akinori Rokuhara; Xiaohong Sun; Eiji Tanaka; Tatsuji Kimura; Akihiro Matsumoto; Dongmei Yao; Lei Yin; Na Wang; Noboru Maki; Kendo Kiyosawa
Journal:  J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 4.029

7.  Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo.

Authors:  Guang-Feng Shi; Qian Li
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

8.  Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system.

Authors:  Marta R Romero; Thomas Efferth; Maria A Serrano; Beatriz Castaño; Rocio I R Macias; Oscar Briz; Jose J G Marin
Journal:  Antiviral Res       Date:  2005-08-10       Impact factor: 5.970

Review 9.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

10.  Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Authors:  Yi-Min Mao; Min-De Zeng; Lun-Gen Lu; Mo-Bin Wan; Cheng-Zhong Li; Cheng-Wei Chen; Qing-Chuen Fu; Ji-Yao Wang; Wei-Min She; Xiong Cai; Jun Ye; Xia-Qiu Zhou; Hui Wang; Shan-Ming Wu; Mei-Fang Tang; Jin-Shui Zhu; Wei-Xiong Chen; Hui-Quan Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

View more
  11 in total

1.  Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats.

Authors:  Yi-cheng Jian; Wei Li; Yi He; Ming Jiang; Yan-bing Liu; Wu-jun Xiong
Journal:  Chin J Integr Med       Date:  2012-07-22       Impact factor: 1.978

2.  Qushi Huayu Decoction (祛湿化瘀方) inhibits protein and gene expression of cathepsin B in HepG2 cells induced by free fatty acids.

Authors:  Qin Feng; Yang Cheng; Yi-yang Hu; Hui Zhang; Jing-hua Peng; Ning Zhang
Journal:  Chin J Integr Med       Date:  2010-11-26       Impact factor: 1.978

3.  Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro.

Authors:  Wen-Sheng Xu; Ke-Kai Zhao; Xiao-Hui Miao; Wu Ni; Xiong Cai; Rui-Qi Zhang; Jun-Xue Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

4.  The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro.

Authors:  Xiang Li; Yuanyuan Liu; Tingting Wu; Yue Jin; Jianpin Cheng; Changbiao Wan; Weihe Qian; Fei Xing; Weifeng Shi
Journal:  Viruses       Date:  2015-08-19       Impact factor: 5.048

5.  Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.

Authors:  Ningning Zheng; Jianye Dai; Huijuan Cao; Shujun Sun; Junwei Fang; Qianhua Li; Shibing Su; Yongyu Zhang; Mingfeng Qiu; Shuang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-18       Impact factor: 2.629

6.  San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.

Authors:  J C Lee; C K Tseng; S F Wu; F R Chang; C C Chiu; Y C Wu
Journal:  J Viral Hepat       Date:  2011-01-20       Impact factor: 3.728

Review 7.  Antiviral Properties of Baicalin: a Concise Review.

Authors:  Kunwei Li; Yiyu Liang; Ao Cheng; Qi Wang; Ying Li; Haocheng Wei; Changzheng Zhou; Xinhuan Wan
Journal:  Rev Bras Farmacogn       Date:  2021-10-06       Impact factor: 2.010

8.  Baicalin Induces a Potent Innate Immune Response to Inhibit Respiratory Syncytial Virus Replication via Regulating Viral Non-Structural 1 and Matrix RNA.

Authors:  Sheng Qin; Xianzhang Huang; Shaogang Qu
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

9.  Baicalein, Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses.

Authors:  Mann-Jen Hour; Su-Hua Huang; Ching-Yao Chang; Yen-Kuan Lin; Ching-Ying Wang; Yuan-Shiun Chang; Cheng-Wen Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-20       Impact factor: 2.629

10.  Baicalin Alleviates Lipopolysaccharide-Induced Liver Inflammation in Chicken by Suppressing TLR4-Mediated NF-κB Pathway.

Authors:  Ping Cheng; Tong Wang; Wei Li; Ishfaq Muhammad; He Wang; Xiaoqi Sun; Yuqi Yang; Jiarui Li; Tianshi Xiao; Xiuying Zhang
Journal:  Front Pharmacol       Date:  2017-08-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.